Higano CS - Search Results

1

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.

Beer TM, Armstrong AJ, Rathkopf D, Loriot Y, Sternberg CN, Higano CS, Iversen P, Evans CP, Kim CS, Kimura G, Miller K, Saad F, Bjartell AS, Borre M, Mulders P, Tammela TL, Parli T, Sari S, van Os S, Theeuwes A, Tombal B. Beer TM, et al. Among authors: higano cs. Eur Urol. 2017 Feb;71(2):151-154. doi: 10.1016/j.eururo.2016.07.032. Epub 2016 Jul 28. Eur Urol. 2017. PMID: 27477525 Free PMC article. Clinical Trial.

2

The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.

Cherrier MM, Rose AL, Higano C. Cherrier MM, et al. J Urol. 2003 Nov;170(5):1808-11. doi: 10.1097/01.ju.0000091640.59812.83. J Urol. 2003. PMID: 14532781 Clinical Trial.

3

Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment.

Carroll PR, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M 3rd, Sellers WR, Smith MR, McMann MC, Kantoff PW. Carroll PR, et al. Among authors: higano cs. J Urol. 2003 Dec;170(6 Pt 2):S3-5. doi: 10.1097/01.ju.0000095101.18470.a0. J Urol. 2003. PMID: 14610403 Review. No abstract available.

4

Management of bone loss in men with prostate cancer.

Higano CS. Higano CS. J Urol. 2003 Dec;170(6 Pt 2):S59-63; discussion S64. doi: 10.1097/01.ju.0000097351.48848.1f. J Urol. 2003. PMID: 14610412 Review.

5

Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer.

Beer TM, Garzotto M, Lowe BA, Ellis WJ, Montalto MA, Lange PH, Higano CS. Beer TM, et al. Among authors: higano cs. Clin Cancer Res. 2004 Feb 15;10(4):1306-11. doi: 10.1158/1078-0432.ccr-1021-03. Clin Cancer Res. 2004. PMID: 14977829 Clinical Trial.

6

Metastases of prostate cancer express estrogen receptor-beta.

Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Lai JS, et al. Among authors: higano cs. Urology. 2004 Oct;64(4):814-20. doi: 10.1016/j.urology.2004.05.036. Urology. 2004. PMID: 15491740

7

Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.

Smith MR, Kabbinavar F, Saad F, Hussain A, Gittelman MC, Bilhartz DL, Wynne C, Murray R, Zinner NR, Schulman C, Linnartz R, Zheng M, Goessl C, Hei YJ, Small EJ, Cook R, Higano CS. Smith MR, et al. Among authors: higano cs. J Clin Oncol. 2005 May 1;23(13):2918-25. doi: 10.1200/JCO.2005.01.529. J Clin Oncol. 2005. PMID: 15860850 Clinical Trial.

8

Current status of treatment for patients with metastatic prostate cancer.

Higano CS. Higano CS. Can J Urol. 2005 Jun;12 Suppl 2:38-41. Can J Urol. 2005. PMID: 16018832 Review.

9

Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer.

Garzotto M, Myrthue A, Higano CS, Beer TM. Garzotto M, et al. Among authors: higano cs. Urol Oncol. 2006 May-Jun;24(3):254-9. doi: 10.1016/j.urolonc.2005.11.034. Urol Oncol. 2006. PMID: 16678060 Clinical Trial.

10

The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.

Saad F, Higano CS, Sartor O, Colombel M, Murray R, Mason MD, Tubaro A, Schulman C. Saad F, et al. Among authors: higano cs. Clin Genitourin Cancer. 2006 Mar;4(4):257-62. doi: 10.3816/CGC.2006.n.004. Clin Genitourin Cancer. 2006. PMID: 16729908 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters